GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » Cyclically Adjusted Revenue per Share

Raia Drogasil (Raia Drogasil) Cyclically Adjusted Revenue per Share : $2.79 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Raia Drogasil's adjusted revenue per share for the three months ended in Mar. 2024 was $1.096. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $2.79 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Raia Drogasil's average Cyclically Adjusted Revenue Growth Rate was 15.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 18.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 18.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Raia Drogasil was 18.60% per year. The lowest was 18.00% per year. And the median was 18.60% per year.

As of today (2024-06-10), Raia Drogasil's current stock price is $4.34. Raia Drogasil's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $2.79. Raia Drogasil's Cyclically Adjusted PS Ratio of today is 1.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Raia Drogasil was 3.18. The lowest was 1.54. And the median was 2.12.


Raia Drogasil Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Raia Drogasil's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Cyclically Adjusted Revenue per Share Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.83 1.71 2.02 2.46 3.57

Raia Drogasil Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.35 2.58 2.62 3.57 2.79

Competitive Comparison of Raia Drogasil's Cyclically Adjusted Revenue per Share

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Cyclically Adjusted PS Ratio falls into.



Raia Drogasil Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Raia Drogasil's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.096/159.3724*159.3724
=1.096

Current CPI (Mar. 2024) = 159.3724.

Raia Drogasil Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.465 91.838 0.807
201409 0.477 92.602 0.821
201412 0.443 94.194 0.750
201503 0.000 97.799 0.000
201506 0.000 100.006 0.000
201509 0.000 101.392 0.000
201512 1.339 104.247 2.047
201603 0.397 106.979 0.591
201606 0.475 108.851 0.695
201609 0.521 109.986 0.755
201612 0.532 110.802 0.765
201703 1.139 111.869 1.623
201706 0.573 112.115 0.815
201709 1.271 112.777 1.796
201712 0.620 114.068 0.866
201803 0.611 114.868 0.848
201806 0.559 117.038 0.761
201809 0.534 117.881 0.722
201812 0.601 118.340 0.809
201903 0.601 120.124 0.797
201906 0.640 120.977 0.843
201909 0.652 121.292 0.857
201912 0.680 123.436 0.878
202003 0.591 124.092 0.759
202006 0.502 123.557 0.648
202009 0.548 125.095 0.698
202012 0.629 129.012 0.777
202103 0.577 131.660 0.698
202106 0.677 133.871 0.806
202109 0.678 137.913 0.783
202112 0.665 141.992 0.746
202203 0.761 146.537 0.828
202206 0.858 149.784 0.913
202209 0.863 147.800 0.931
202212 0.905 150.207 0.960
202303 0.905 153.352 0.941
202306 1.039 154.519 1.072
202309 1.040 155.464 1.066
202312 1.062 157.148 1.077
202403 1.096 159.372 1.096

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Raia Drogasil  (OTCPK:RADLY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Raia Drogasil's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.34/2.79
=1.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Raia Drogasil was 3.18. The lowest was 1.54. And the median was 2.12.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Raia Drogasil Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (Raia Drogasil) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (Raia Drogasil) Headlines

From GuruFocus

Q3 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Raia Drogasil SA Day Transcript

By GuruFocus Research 02-14-2024